Michael M. Kitt

Effect of Telavancin on the Pharmacokinetics of the Cytochrome P450 3A Probe Substrate Midazolam: A Randomized, Double‐Blind, Crossover Study in Healthy Subjects

S. Barriere, C. Ballow, M. Kitt, 2010, Pharmacotherapy.

Single‐Dose Pharmacokinetics and Tolerability of Telavancin in Elderly Men and Women

J. Shaw, S. Barriere, M. Kitt, 2010, Pharmacotherapy.

Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.

V. Fowler, C. Cabell, W. O'Riordan, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.